The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings
Abstract
Background: The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? Method: A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: ‘antipsychotics’ AND ‘brain’ AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Results: Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Conclusions: Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Lawrie, S. M., & Abukmeil, S. S. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.2.110 · Cited by 843
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A. W., & Rapoport, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201243998 · Cited by 812
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Lieberman, J. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.361 · Cited by 801
McCarley, R. W., Wible, C. G., Frumin, M., Hirayasu, Y., Levitt, J. J., Fischer, I. A., & Shenton, M. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00018-9 · Cited by 729
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1430 · Cited by 556
Longitudinal study of brain morphology in first episode schizophrenia
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., & Bilder, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01067-8 · Cited by 554
Gur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., & Gur, R. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.145 · Cited by 540
Ho, B.-C., Andreasen, N. C., Nopoulos, P., Arndt, S., Magnotta, V., & Flaum, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.585 · Cited by 536
Dorph-Petersen, K.-A., Pierri, J. N., Perel, J. M., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300710 · Cited by 437
Subcortical MRI Volumes in Neuroleptic-Naive and Treated Patients With Schizophrenia
Gur, R. E., Maany, V., Mozley, P. D., Swanson, C., Bilker, W., & Gur, R. C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1711 · Cited by 434
Brain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study
Cahn, W., Pol, H. E. H., Lems, E. B. T. E., van Haren, N. E. M., Schnack, H. G., van der Linden, J. A., Schothorst, P. F., van Engeland, H., & Kahn, R. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1002 · Cited by 400
Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia
Gur, R. E., Cowell, P. E., Latshaw, A., Turetsky, B. I., Grossman, R. I., Arnold, S. E., Bilker, W. B., & Gur, R. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.761 · Cited by 368
Hulshoff Pol, H. E., & Kahn, R. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm168 · Cited by 364
Velakoulis, D., Pantelis, C., McGorry, P. D., Dudgeon, P., Brewer, W., Cook, M., Desmond, P., Bridle, N., Tierney, P., Murrie, V., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.133 · Cited by 354
Changes in caudate volume with neuroleptic treatment
KESHAVAN, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90599-1 · Cited by 291
Weinberger, D. R., & McClure, R. K. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.553 · Cited by 260
Dazzan, P., Morgan, K. D., Orr, K., Hutchinson, G., Chitnis, X., Suckling, J., Fearon, P., McGuire, P. K., Mallett, R. M., Jones, P. B., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300603 · Cited by 259
Self-citationCorson, P. W., Nopoulos, P., Miller, D. D., Arndt, S., & Andreasen, N. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1200 · Cited by 254
Nyberg, S., Eriksson, B., Oxenstierna, G., Halldin, C., & Farde, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.869 · Cited by 251
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine
Chakos, M., Lieberman, J., Alvir, J., Bilder, R., & Ashtari, M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90441-7 · Cited by 250
Effects of antipsychotics on brain structure
Scherk, H., & Falkai, P. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214339.06507.d8 · Cited by 246
Millan, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2199-1 · Cited by 221
Cortical Thinning in Cingulate and Occipital Cortices in First Episode Schizophrenia
Narr, K. L., Toga, A. W., Szeszko, P., Thompson, P. M., Woods, R. P., Robinson, D., Sevy, S., Wang, Y., Schrock, K., & Bilder, R. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.043 · Cited by 200
Effects of Chronic Haloperidol and Clozapine Treatment on Neurogenesis in the Adult Rat Hippocampus
Halim, N. D., Weickert, C. S., McClintock, B. W., Weinberger, D. R., & Lipska, B. K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300422 · Cited by 189
Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat
Wang, H.-D., Dunnavant, F. D., Jarman, T., & Deutch, A. Y. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300449 · Cited by 162
Shihabuddin, L., Buchsbaum, M. S., Hazlett, E. A., Haznedar, M. M., Harvey, P. D., Newman, A. C., Schnur, D. B., Spiegel-Cohen, J., Wei, T.-C., Macháč, J., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.235 · Cited by 152
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
Chakos, M., Schobel, S., Gu, H., Gerig, G., Bradford, D. W., Charles, C. H., & Lieberman, J. A. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.1.26 · Cited by 149
Post, A., Holsboer, F., & Behl, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08236.1998 · Cited by 146
Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment
Frazier, J. A., Giedd, J. N., Kaysen, D. L., Albus, K. E., Hamburger, S., Alaghband‐Rad, J., Lenane, M., McKenna, K., Breier, A. F., & Rapoport, J. L. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.564 · Cited by 141
Scheepers, F. E., de Wied, C. C., Pol, H. E. H., van de Flier, W., van der Linden, J. A., & Kahn, R. S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00172-x · Cited by 133
Lang, D. J., Kopala, L. C., Vandorpe, R. A., Rui, Q., Smith, G. N., Goghari, V. M., & Honer, W. G. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.625 · Cited by 133
Miller, D. D., Andreasen, N. C., OʼLeary, D. S., Watkins, G. L., Ponto, L. L. B., & Hichwa, R. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01001-5 · Cited by 128
Corson, P. W., Nopoulos, P., Andreasen, N. C., Heckel, D., & Arndt, S. V. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00079-7 · Cited by 107
Cerebral Cortical Gray Expansion Associated with Two Second-Generation Antipsychotics
Garver, D. L., Holcomb, J. A., & Christensen, J. D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.008 · Cited by 103
Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography
Miller, D. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00042-0 · Cited by 103
An Update of Fast-Off Dopamine D2 Atypical Antipsychotics
Seeman, P. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1984-a · Cited by 101
Duncan, G. E., Zorn, S. J., & Lieberman, J. A. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000581 · Cited by 100
Lang, D. J., Kopala, L. C., Vandorpe, R. A., Rui, Q., Smith, G. N., Goghari, V. M., Lapointe, J. S., & Honer, W. G. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1829 · Cited by 87
Massana, G., Salgado‐Pineda, P., Junqué, C., Pérez, M. P., Baeza, I., Pons, A., Massana, J., Navarro, V. S., Blanch, J., Morer, Á., et al. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155818.29091.53 · Cited by 87
Wright, A. M., Bempong, J., Kirby, M. L., Barlow, R. L., & Bloomquist, J. R. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01551-5 · Cited by 85
Angelucci, F., Aloe, L., Iannitelli, A., Gruber, S. H. M., & Mathé, A. A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.11.005 · Cited by 83
Effect of Clozapine on Caudate Nucleus Volume in Relation to Symptoms of Schizophrenia
Scheepers, F. E., Wied, C. C. G., Pol, H. E. H., & Kahn, R. S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.644 · Cited by 75
Miller, D. D., Rezai, K., Alliger, R. J., & Andreasen, N. C. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00110-2 · Cited by 74
Puri, B. K., Hutton, S. B., Saeed, N., Oatridge, A., Hajnal, J. V., Duncan, L.-J., Chapman, M. J., Barnes, T. R. E., Bydder, G. M., & Joyce, E. M. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00072-5 · Cited by 74
Oosthuizen, P. P., Emsley, R. A., Turner, H. J., & Keyter, N. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004262 · Cited by 72
Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment
McClure, R. K., Phillips, I., Jazayerli, R., Barnett, A., Coppola, R., & Weinberger, D. R. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.04.008 · Cited by 71
Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801
Fumagalli, F., Molteni, R., Bedogni, F., Gennarelli, M., Pérez, J., Racagni, G., & Riva, M. A. (2004) · Neuroreport · doi:10.1097/00001756-200409150-00022 · Cited by 70
State-related changes in cerebral white matter may underlie psychosis exacerbation
Christensen, J., Holcomb, J. A., & Garver, D. L. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2003.08.002 · Cited by 70
Nopoulos, P., Ceilley, J. W., Gailis, E. A., & Andreasen, N. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01059-3 · Cited by 63
Dean, C. E. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.019 · Cited by 59
Risperidone in first-episode psychosis: A longitudinal, exploratory voxel-based morphometric study
Girgis, R. R., Diwadkar, V. A., Nutche, J. J., Sweeney, J. A., Keshavan, M. S., & Hardan, A. Y. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.019 · Cited by 56
Heitmiller, D. R., Nopoulos, P., & Andreasen, N. C. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.08.008 · Cited by 54
Magnetic resonance imaging of the thalamus in male patients with schizophrenia
Deicken, R. F., Eliaz, Y., Chosiad, L., Feiwell, R., & ROGERS, L. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00330-9 · Cited by 42
MRI correlates of treatment response in first episode psychosis
Zipursky, R. B., Zhang-Wong, J., Lambe, E. K., Bean, G., & Beiser, M. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00126-6 · Cited by 40
Khorram, B., Lang, D. J., Kopala, L. C., Vandorpe, R. A., Rui, Q., Goghari, V. M., Smith, G. N., & Honer, W. G. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.2005 · Cited by 35
Tauscher‐Wisniewski, S., Tauscher, J. T., Logan, J., Christensen, B. K., Mikulis, D. J., & Zipursky, R. B. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00406-6 · Cited by 33
Taylor, S. F., Christensen, J. D., Holcomb, J. A., & Garver, D. L. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.06.004 · Cited by 27
Schizophrenia is (not simply) a neurodevelopmental disorder
Dazzan, P., & Murray, R. M. (1999) · Epidemiology and Psychiatric Sciences · doi:10.1017/s1121189x00008137 · Cited by 10
Self-citationMathalon, D. H., Sullivan, E. V., Lim, K. O., & Pfefferbaum, A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.148
Cited by
Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
Haijma, S. V., Van Haren, N., Cahn, W., Koolschijn, P. C. M. P., Hulshoff Pol, H. E., & Kahn, R. S. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs118 · Cited by 1,012
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971
van Erp, T. G. M., Walton, E., Hibar, D. P., Schmaal, L., Jiang, W., Glahn, D. C., Pearlson, G. D., Yao, N., Fukunaga, M., Hashimoto, R., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.023 · Cited by 934
Self-citationDysconnectivity in schizophrenia: where are we now?
Pettersson-Yeo, W., Allen, P., Benetti, S., McGuire, P., & Mechelli, A. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.11.004 · Cited by 712
Cannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T. G. M., McEwen, S., Addington, J., Bearden, C. E., Cadenhead, K., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.023 · Cited by 599
“Antipsychotic drugs are associated with gray matter decline in animal models (13) and in patients with schizophrenia (14, 15), including first-episode patients (16).”
Background
Metadata
- Authors
- Navari, S., & Dazzan, P.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2009-04-02
- Volume
- 39
- Issue
- 11
- Pages
- 1763-1777
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2117987967
- Cited by
- 336
- References
- 65
- FWCI
- 18.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.